Sumitra Deb

Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Molecular Biology
"Sumitra Deb"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Frum RA, Love IM, Damle P, et al. (2016) Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination. Molecular Cancer Research : McR
Biddlestone-Thorpe L, Sajjad M, Rosenberg E, et al. (2013) ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3189-200
Deb S, Graves PR. (2013) Identification of novel mutant p53 interacting proteins by proteomic analysis. Methods in Molecular Biology (Clifton, N.J.). 962: 85-94
Sankala H, Vaughan C, Wang J, et al. (2011) Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance. Archives of Biochemistry and Biophysics. 512: 52-60
Deb D, Chakraborti AS, Lányi A, et al. (1999) Disruption of functions of wild-type p53 by hetero-oligomerization. International Journal of Oncology. 15: 413-22
Lányi A, Deb D, Seymour RC, et al. (1998) 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain. Oncogene. 16: 3169-76
See more...